Skip to main content

Advertisement

Log in

Oncogenic mechanisms in myeloproliferative disorders

  • Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Myeloproliferative disorders (MPDs) are clonal haematopoietic malignancies involving the abnormal proliferation of myeloid lineages. The World Health Organisation (WHO) classification of haematopoietic malignancies distinguishes MPDs from myelodysplastic/ myeloproliferative disorders and systemic mastocytosis. These malignancies frequently involve constitutive tyrosine kinase activity, resulting from either oncogenic fusion protein production or from point mutations. Chronic myelogenous leukaemia is the model used for studies of the consequences of such molecular defects. However, the heterogeneity of the clinical course of MPDs should be seen in a more rationale conceptual framework, including the many molecular events associated with these diseases. This review focuses on the various tyrosine kinase-related molecular mechanisms underlying both MPDs and rare diseases with myeloproliferative features. We pay particular attention to the newly identified JAK2 V617F mutation in polycythaemia vera, essential thrombocythaemia and idiopathic myelofibrosis and deal with disease heterogeneity and putative additional molecular mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Vainchenker.

Additional information

Received 9 June 2006; received after revision 28 July 2006; accepted 11 September 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delhommeau, F., Pisani, D.F., James, C. et al. Oncogenic mechanisms in myeloproliferative disorders. Cell. Mol. Life Sci. 63, 2939–2953 (2006). https://doi.org/10.1007/s00018-006-6272-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-006-6272-7

Keywords.

Navigation